Article
Hoffman Decides on BTK Inhibitor Therapy in a Patient With Relapsed CLL and Del(17p)
Rating:
0.0
Views:
82
Likes:
1
Library:
1
During a Targeted Oncology Case Based Peer Perspective event, Marc Hoffman, MD, reviewed the case of a 53-year-old woman with relapsed chronic lymphocytic leukemia.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value